2. NF-κB Stem Cell/Wnt JAK/STAT Signaling Apoptosis
  3. IKK STAT Apoptosis
  4. TPCA-1

TPCA-1 

Cat. No.: HY-10074 Purity: 99.72%
COA Handling Instructions

TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.

For research use only. We do not sell to patients.

TPCA-1 Chemical Structure

TPCA-1 Chemical Structure

CAS No. : 507475-17-4

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent
10 mM * 1 mL in DMSO
ready for reconstitution
 USD 111 In-stock
Solution
10 mM * 1 mL in DMSO USD 111 In-stock
Solid
5 mg USD 77 In-stock
10 mg USD 121 In-stock
50 mg USD 352 In-stock
100 mg USD 539 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 28 publication(s) in Google Scholar

TPCA-1 Related Antibodies

Top Publications Citing Use of Products

    TPCA-1 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2018 Apr 27;9(5):500.  [Abstract]

    Western blotting analysis of lysates from 3×HA-IκBα-expressing HT-29 cells treated as indicated for 8 h.

    TPCA-1 purchased from MedChemExpress. Usage Cited in: J Immunol. 2016 May 15;196(10):4322-30.  [Abstract]

    HEK293T (IRF3-BiLC) cells are pretreated with TPCA-1 for 1 h, stimulated with TNF-α for 12 h, and then transfected with poly(I:C) for 12 h, after which IRF3-BiLC luciferase activity is measured.

    TPCA-1 purchased from MedChemExpress. Usage Cited in: ACS Nano. 2015 Dec 22;9(12):11800-11.  [Abstract]

    Neutrophil-mediated delivery of TPCA-1 mitigates acute lung inflammation/injury. Numbers of leukocytes and neutrophils, concentrations of IL-6 in BALF 20 h after iv injection of vehicle of TPCA-1 solution, 5% glucose, TPCA-1 solution or TPAC-1 BSA NPs in mice 4 h after LPS challenge (8 mg/kg).

    View All IKK Isoform Specific Products:

    View All Isoforms
    IKK-α IKK-β IKK IKKε TBK1

    View All STAT Isoform Specific Products:

    View All Isoforms
    STAT3 STAT5 STAT6 STAT1

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    TPCA-1 is a potent and selective inhibitor of IKK-2 with IC50 of 17.9 nM. TPCA-1 is an effective inhibitor of STAT3 phosphorylation, DNA binding, and transactivation.

    IC50 & Target[3]

    IKK-2

    17.9 nM (IC50)

    STAT3

     

    In Vitro

    TPCA-1 inhibits lipopolysaccharide-induced human monocyte production of TNF-α, IL-6, and IL-8 with an IC50 of 170 to 320 nM[1][2].
    ? TPCA-1 (0-2 μM) inhibits STAT3 phosphorylation and transactivation induced by cytokines and nonreceptor tyrosine kinase in dose- and time-dependent manner. TPCA-1 completely inhibits STAT3 phosphorylation without changing total STAT3 levels[3].
    ? TPCA-1 increased sensitivity to ZD1839 in both TKI sensitive cells and insensitive cells[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    TPCA-1 Related Antibodies

    Cell Viability Assay[2]

    Cell Line: human peripheral blood monocytes stimulated with LPS.
    Concentration: 0-10 μM.
    Incubation Time: ~24 hours.
    Result: TPCA-1 Inhibits LPS-Induced TNF-α, IL-6, and IL-8 production by human monocytes.

    Cell Viability Assay[3]

    Cell Line: HCC827 and H1975 cells.
    Concentration: 0-10 μM.
    Incubation Time: 0.5-2 hours.
    Result: Suppressed proliferation of HCC827 and H1975 cells.
    Led to a G2-M cell-cycle arrest in HCC827 but not A549.

    Western Blot Analysis[3]

    Cell Line: HEK-293T cell lines.
    Concentration: 0-2 μM (before IL-2 or IFN-α treatment).
    Incubation Time: 0.5-2 hours.
    Result: Inhibited STAT3 phosphorylation and transactivation induced by cytokines and nonreceptor tyrosine kinase in dose- and time-dependent manner.
    In Vivo

    TPCA-1 (3, 10, or 20 mg/kg, i.p.) results in a dose-dependent reduction in the severity of murine collagen-induced arthritis (CIA)[2].
    ? TPCA-1(10 mg/kg, i.p. daily) inhibits growth of NSCLC with EGFR mutation and potentiates antitumor effect of ZD1839 in xenograft models[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: 10-12 weeks old male DBA/1 OlaHsd mice[2].
    Dosage: 3, 10, or 20 mg/kg.
    Administration: I.P., b.i.d, from days 1 to 47.
    Result: Reduced the severity and delays the onset of CIA.
    Attenuated ex vivo antigen-induced T cell proliferation in CIA.
    Animal Model: Six-week-old BALB/c female nude mice injected subcutaneously with HCC827 cells (5×106)[3].
    Dosage: 10 mg/kg.
    Administration: Intraperitoneally daily.
    Result: The tumor weight inhibition rate of TPCA-1, ZD1839, and their combination are 0.419(ETPCA-1), 0.680(EZD1839), and 0.837(Eobserved), respectively.
    Molecular Weight

    279.29

    Appearance

    Solid

    Formula

    C12H10FN3O2S
    CAS No.
    SMILES

    O=C(C1=C(NC(N)=O)SC(C2=CC=C(F)C=C2)=C1)N
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 100 mg/mL (358.05 mM)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.5805 mL 17.9025 mL 35.8051 mL
    5 mM 0.7161 mL 3.5805 mL 7.1610 mL
    10 mM 0.3581 mL 1.7903 mL 3.5805 mL
    *Please refer to the solubility information to select the appropriate solvent.
    In Vivo:
    • 1.

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 7.5 mg/mL (26.85 mM); Clear solution

    • 2.

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 7.5 mg/mL (26.85 mM); Clear solution

    • 3.

      Add each solvent one by one:  10% DMSO    90% Corn Oil

      Solubility: ≥ 7.5 mg/mL (26.85 mM); Clear solution

    *All of the co-solvents are available by MedChemExpress (MCE).
    Purity & Documentation

    Purity: 99.72%

    COA (251 KB) LCMS (266 KB)

    Handling Instructions (2659 KB)
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    TPCA-1 Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    Keywords:

    TPCA-1507475-17-4TPCA1TPCA 1IKKSTATApoptosisIκB kinaseI kappa B kinase Inhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Salutation

    Applicant Name *

    		 

    Email Address *

    Phone Number *

    		 

    Organization Name *

    Department *

    		 

    Requested quantity *

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    TPCA-1
    Cat. No.:
    HY-10074
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.